Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

China Sky One Moves Ahead on Diagnostic Kit for Cardiac Problems

publication date: May 4, 2009

China Sky One Medical (中国天字一号医药公司) announced that the R&D behind its Sudden Cardiac Death (SCD) Early Examination Kit was examined by the Heilongjiang Bureau of Science and Technology, which concluded that the research was reliably conducted. The decision allows China Sky One to begin clinical trials on its SCD Kit. In 2008, Prof. Baofeng Yang, Principal of Harbin Medical University and Chief Scientist of Chinese National 973 Project, found a positive correlation between the concentration of a substance called "MicroRNA-1" in human blood and the occurrence of SCD. More details...

Stock Symbol: (NSDQ: CSKI)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital